Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn’s Disease Treated with Anti-Tumour Necrosis Factor Therapy - Messadeg, L; Hordonneau, C; Bouguen, G (Journal of Crohn's and Colitis, 2020)
et al.